Hodgkin Disease: all 914 studies
Page 9 of 10. Open to participants first (136), then studies with results posted, then the rest; newest registration first within each.
- Psychosocial Impact of Cancer-Related Female InfertilityCompletedNCT00386217
- Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's LymphomaTerminatedNCT00383097Phase 1
- Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's LymphomaActive, not recruitingNCT00379041Phase 3
- Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)Active, not recruitingNCT00368082Phase 1
- Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00364676Phase 1
- Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's LymphomaCompletedNCT00359892Phase 2
- Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's LymphomaTerminatedNCT00358982Phase 2
- PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomaTerminatedNCT00354185Phase 1
- PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasCompletedNCT00348985Phase 1
- Rituximab in Primary Lymphocyte Predominant Hodgkin´s Disease(RIPL)CompletedNCT00346684Phase 2
- Genome Expression in Lymphoma, Leukemia and Multiple MyelomaCompletedNCT00339963
- Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other DiseasesCompletedNCT00317785Phase 2
- Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin LymphomaCompletedNCT00305149Not applicable
- Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00301951Phase 1
- A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).CompletedNCT00301314
- 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00293345Phase 1
- Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)CompletedNCT00285259Phase 2
- A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's DiseaseCompletedNCT00284804Phase 2
- Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins LymphomaCompletedNCT00284271Phase 2
- HD12 for Advanced StagesCompletedNCT00265031Phase 3
- HD10 for Early StagesCompletedNCT00265018Phase 3
- HD11 for Intermediate StagesCompletedNCT00264953Phase 3
- A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing ChemotherapyCompletedNCT00261677Phase 3
- Study of TPI 287 Administered Every 21 Days in Patients With Advanced MalignanciesCompletedNCT00256191Phase 1
- Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/LymphomaCompletedNCT00232440Phase 1/2
- Combination Chemotherapy +/- Radiation in High Risk Hodgkin's DiseaseTerminatedNCT00225173Phase 2
- Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's DiseaseTerminatedNCT00209014Phase 2
- Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise TrainingCompletedNCT00196885Phase 2
- Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PETStatus unknownNCT00188149Phase 4
- High Dose Chemotherapy Followed By PBSC Rescue for HDCompletedNCT00186251Not applicable
- Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid TumorsStatus unknownNCT00179816Phase 1/2
- Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based ChemotherapyCompletedNCT00165438
- Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal IrradiationActive, not recruitingNCT00165425Not applicable
- Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's DiseaseCompletedNCT00165412
- Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease SurvivorsCompletedNCT00165308Not applicable
- Mantle Irradiation for Hodgkin's DiseaseCompletedNCT00165269Phase 2
- Efficacy Study of Outpatient Therapy for LymphomaCompletedNCT00163761Phase 2
- Efficacy and Treatment Related Toxicity Study of a New Regimen for LymphomaCompletedNCT00163748Phase 2
- Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's LymphomaTerminatedNCT00148018Phase 2
- Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's LymphomaCompletedNCT00147875Phase 1/2
- Haploidentical Stem Cell Transplant for Treatment Refractory Hematological MalignanciesCompletedNCT00145613Phase 2
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell TransplantationCompletedNCT00144703Phase 2
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell TransplantationCompletedNCT00144677Phase 2
- Amifostine for Head and Neck Irradiation in LymphomaCompletedNCT00136474Phase 2
- Study of Unrelated Cord Blood Transplantation Using Tacrolimus and SirolimusCompletedNCT00133367Phase 2
- Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's DiseaseWithdrawnNCT00129753Phase 2
- Study of TPI 287 in Patients With Advanced MalignanciesCompletedNCT00113724Phase 1
- SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's LymphomaTerminatedNCT00101244Phase 1
- MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or LymphomasCompletedNCT00098891Phase 1
- Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasTerminatedNCT00096005Phase 1
- Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00090909Phase 2
- 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomasCompletedNCT00089271Phase 1
- CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaTerminatedNCT00086840Phase 2
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's LymphomaCompletedNCT00086801Phase 2
- Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00082966Phase 2
- A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 YearsCompletedNCT00079105Phase 2
- Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantCompletedNCT00078858Phase 1/2
- Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00077155Phase 1
- Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory LymphomaCompletedNCT00061672Phase 2
- Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerCompletedNCT00060372Phase 1
- Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or LymphomaTerminatedNCT00060112Phase 1
- Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin DiseaseTerminatedNCT00058773Phase 1
- Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGELCompletedNCT00058617Phase 1
- A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic MalignanciesCompletedNCT00051597Phase 1/2
- Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's LymphomaCompletedNCT00049595Phase 3
- Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00044954Phase 2
- Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of ThrombocytopeniaCompletedNCT00039910Phase 3
- Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic CancerActive, not recruitingNCT00039676
- CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell TransplantationTerminatedNCT00038818Not applicable
- Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD ChemotherapyCompletedNCT00038558Phase 3
- Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or LymphomaCompletedNCT00027937Phase 2
- Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00027820Phase 1/2
- Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00025415Phase 1
- Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesCompletedNCT00014235Not applicable
- Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous TreatmentCompletedNCT00014209Phase 2
- Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic MalignanciesCompletedNCT00013533Early Phase 1
- Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain TumorCompletedNCT00006342
- Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerCompletedNCT00006251Phase 1/2
- PS-341 in Treating Patients With Hematologic CancerCompletedNCT00006098Phase 1
- Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseWithdrawnNCT00005998Phase 2
- Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's DiseaseWithdrawnNCT00005969Phase 2
- Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous TreatmentCompletedNCT00005811Phase 2
- Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00005799Not applicable
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's DiseaseTerminatedNCT00005595Phase 2
- Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's LymphomaActive, not recruitingNCT00005584Phase 3
- Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's DiseaseCompletedNCT00005578Phase 3
- S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's DiseaseTerminatedNCT00005090Phase 3
- Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedNCT00004908Phase 2
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaCompletedNCT00004241Phase 1
- Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedNCT00004171Phase 2
- Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's DiseaseCompletedNCT00004169Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's DiseaseCompletedNCT00004010Phase 2
- Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaCompletedNCT00003970Phase 1
- Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's DiseaseCompletedNCT00003936Phase 2
- Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaStatus unknownNCT00003924Phase 3
- Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00003849Phase 2
- Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's LymphomaCompletedNCT00003741Phase 1
- Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1
- Combination Chemotherapy in Treating Patients With Advanced Hodgkin's DiseaseCompletedNCT00003421Phase 3
- Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV InfectionStatus unknownNCT00003262Phase 2